ELVN   $30.05  10.28% Market Closed After Close 30.05 0.0

Enliven Therapeutics, Inc.

EMA (20): 2026-02-23 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2026-01-08 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-01-08 the price crossed up the moving average line and demonstrates an upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: exit from the overbought zone.

Trend Type flat and up
Power slow
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 4.74%
EMA (20) date of signal Feb. 23, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 23.66%
EMA (50) date of signal Jan. 8, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 23.66%
EMA (100) date of signal Jan. 8, 2026, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield -2.54%
RSI (14) date of signal March 2, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield 0.0
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bearish reversal
Stochastic Yield 0.0
Stochastic date of signal March 3, 2026, 3 a.m.
Updated March 4, 2026, 8:22 p.m.